ArticleNature communications2025
Photoredox-controlled alternating copolymerization enables highly crystalline structures and block copolymers from thermoplastic to elastomer.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Ethylene-based crystalline copolymers are important materials across broad applications. However, precise control over their primary structures remains a critical challenge in advancing functional materials, limited by the intrinsic reactivity difference between ethylene and comonomers. In this work, we report the development of a light-driven organocatalyzed reversible-deactivation radical copolymerization to access well-defined ethylene-chlorotrifluoroethylene copolymer (ECTFE) under mild conditions (<5 atm, 25 °C). The rational design of a three-armed phenothiazine catalyst in combination with a fluorinated dithiocarbamate furnishes good chain-growth control in the photoredox-mediated copolymerization, yielding ECTFE of excellent alternating sequence with minimized chain defects, which resulted in high crystallinity and superior melting points (up to 263.8 °C). Importantly, the obtained ECTFE exhibits outstanding chain-end activity/fidelity, enabling chain-extension (co)polymerization to access a variety of unprecedented ECTFE-based block copolymers upon visible-light exposure, which has successfully integrated rigid and soft blocks in single chains. The ease of synthesizing such block copolymers creates a versatile and convenient platform to largely tune mechanical properties, affording polymeric materials spanning from thermoplastics to elastomers via structural tailoring.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.